Lantheus Holdings Inc (LNTH)
62.25
+1.79
(+2.96%)
USD |
NASDAQ |
Mar 28, 16:00
62.25
0.00 (0.00%)
After-Hours: 20:00
Lantheus Holdings Research and Development Expense (Quarterly): 16.82M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.82M |
September 30, 2023 | 14.45M |
June 30, 2023 | 15.90M |
March 31, 2023 | 30.53M |
December 31, 2022 | 272.23M |
September 30, 2022 | 12.52M |
June 30, 2022 | 14.74M |
March 31, 2022 | 12.20M |
December 31, 2021 | 11.29M |
September 30, 2021 | 11.25M |
June 30, 2021 | 12.06M |
March 31, 2021 | 10.36M |
December 31, 2020 | 12.64M |
September 30, 2020 | 11.68M |
June 30, 2020 | 4.418M |
March 31, 2020 | 4.048M |
December 31, 2019 | 4.434M |
September 30, 2019 | 4.86M |
June 30, 2019 | 5.795M |
March 31, 2019 | 4.929M |
December 31, 2018 | 4.551M |
September 30, 2018 | 4.316M |
Date | Value |
---|---|
June 30, 2018 | 4.215M |
March 31, 2018 | 3.989M |
December 31, 2017 | 3.976M |
September 30, 2017 | 3.554M |
June 30, 2017 | 5.244M |
March 31, 2017 | 5.351M |
December 31, 2016 | 3.71M |
September 30, 2016 | 2.849M |
June 30, 2016 | 2.608M |
March 31, 2016 | 3.036M |
December 31, 2015 | 3.066M |
September 30, 2015 | 2.458M |
June 30, 2015 | 2.638M |
March 31, 2015 | 6.196M |
December 31, 2014 | 4.715M |
September 30, 2014 | 3.049M |
June 30, 2014 | 2.687M |
March 31, 2014 | 3.222M |
December 31, 2013 | 5.031M |
September 30, 2013 | 5.893M |
June 30, 2013 | 7.537M |
March 31, 2013 | 12.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.048M
Minimum
Mar 2020
272.23M
Maximum
Dec 2022
24.36M
Average
11.87M
Median
Research and Development Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 5.721M |
Eli Lilly and Co | 2.563B |
Insulet Corp | 42.00M |
Shockwave Medical Inc | 42.32M |
NeuroMetrix Inc | 0.7324M |